https://www.angelinipharma.bg/2026-01-21weekly1https://www.angelinipharma.bg/za-nas/za-andzhelini-farma/2025-10-17yearly0.8https://www.angelinipharma.bg/media/xc4ilu41/ap_site_1030x302.jpgAP Site 1030X302https://www.angelinipharma.bg/za-nas/andzhelini-farma-v-b-lgariya/2025-10-08yearly0.8https://www.angelinipharma.bg/media/xc4ilu41/ap_site_1030x302.jpgAP Site 1030X302https://www.angelinipharma.bg/za-nas/viziya-misiya-i-fennosti/2025-10-28yearly0.8https://www.angelinipharma.bg/media/3fgmbkrc/covermission-vision.jpgDonna di spalle con le braccia aperte di fronte a un lagohttps://www.angelinipharma.bg/za-nas/klyuchovi-fakti-i-s-bitiya/2025-10-08yearly0.8https://www.angelinipharma.bg/media/4hppt051/history.jpgBoccette e scatole antiche di medicinalihttps://www.angelinipharma.bg/za-nas/proizvodstveni-deinosti/2025-10-17monthly0.9https://www.angelinipharma.bg/media/x5dhws3i/sites.jpgSiteshttps://www.angelinipharma.bg/za-nas/proizvodstveni-deinosti/ankona/2023-04-04yearly0.8https://www.angelinipharma.bg/media/g5obpqqr/veduta-aerea-aerial-view.webpVeduta Aerea Aerial Viewhttps://www.angelinipharma.bg/za-nas/proizvodstveni-deinosti/apriliya/2023-04-04yearly0.8https://www.angelinipharma.bg/media/yqfcqorb/testata_aprilia.webpTestata Apriliahttps://www.angelinipharma.bg/za-nas/proizvodstveni-deinosti/олбани-thermacare/2023-04-04yearly0.8https://www.angelinipharma.bg/media/2qjpe5ur/thermacare2.webpThermacare2https://www.angelinipharma.bg/za-nas/proizvodstveni-deinosti/barselona-sant-quirze-del-valles/2023-04-04yearly0.8https://www.angelinipharma.bg/media/tkyjx4qs/stabilimento-barcellona.jpgStabilimento Barcellonahttps://www.angelinipharma.bg/terapevtichni-oblasti/zdrave-na-moz-ka/2025-10-08yearly0.8https://www.angelinipharma.bg/media/vy0ipjq5/brain-health.jpgBrain Healthhttps://www.angelinipharma.bg/terapevtichni-oblasti/zdrave-na-moz-ka/psikhichno-zdrave/2024-10-10yearly0.8https://www.angelinipharma.bg/media/gjdfw1em/20181128162826covermentalhealth.jpgoncologyhttps://www.angelinipharma.bg/terapevtichni-oblasti/zdrave-na-moz-ka/fentralna-nervna-sistema/2023-04-04yearly0.8https://www.angelinipharma.bg/media/0xzhicpo/cns.jpgCNShttps://www.angelinipharma.bg/terapevtichni-oblasti/bolka/2023-04-04yearly0.8https://www.angelinipharma.bg/media/cjmpuyzn/ap_snc_1030x302.jpgAP SNC 1030X302https://www.angelinipharma.bg/terapevtichni-oblasti/onkologiya/2023-04-04monthly0.9https://www.angelinipharma.bg/media/qbabjtp0/rare_deseas_header.jpgRare Deseas Headerhttps://www.angelinipharma.bg/terapevtichni-oblasti/onkologiya/khronichna-mielogenna-levkemiya-khml/2023-04-04yearly0.8https://www.angelinipharma.bg/terapevtichni-oblasti/onkologiya/ostra-limfoblastna-levkimiya/2023-04-04yearly0.8https://www.angelinipharma.bg/terapevtichni-oblasti/onkologiya/nekhodzhkinovi-limfomi/2023-04-04yearly0.8https://www.angelinipharma.bg/terapevtichni-oblasti/pulmologiya/2023-04-04monthly0.9https://www.angelinipharma.bg/media/eqdl5jbg/pulmonology.jpgPulmonologyhttps://www.angelinipharma.bg/terapevtichni-oblasti/pulmologiya/kashlifa/2023-04-04yearly0.8https://www.angelinipharma.bg/terapevtichni-oblasti/pulmologiya/sinuzit/2023-04-04yearly0.8https://www.angelinipharma.bg/terapevtichni-oblasti/pulmologiya/khronichna-obstruktivna-belodrobna-bolest-khobb/2023-04-04yearly0.8https://www.angelinipharma.bg/terapevtichni-oblasti/pulmologiya/khronichen-bronkhit/2023-04-04yearly0.8https://www.angelinipharma.bg/terapevtichni-oblasti/ortopediya-i-revmatologiya/2023-04-04monthly0.9https://www.angelinipharma.bg/media/i3bjujut/orhtopedics.jpgOrhtopedicshttps://www.angelinipharma.bg/terapevtichni-oblasti/ortopediya-i-revmatologiya/osteoartrit/2023-04-04yearly0.8https://www.angelinipharma.bg/terapevtichni-oblasti/consumer-health/2023-04-04yearly0.8https://www.angelinipharma.bg/media/qewpau0z/consumer-health.jpgConsumer Health (1)https://www.angelinipharma.bg/proizvodstvo-i-r-d-deinost/nauchno-izsledovatelska-deinost/2025-10-08yearly0.8https://www.angelinipharma.bg/media/cu0pwcqa/pipeline.jpgPipelinehttps://www.angelinipharma.bg/proizvodstvo-i-r-d-deinost/izsledovatelski-s-trudnichestva/2025-10-10yearly0.8https://www.angelinipharma.bg/media/zrilhr1o/researchacademic_1030.jpgResearchacademic 1030https://www.angelinipharma.bg/produkti/2023-04-04never0.5https://www.angelinipharma.bg/media/zlkn2mal/testata_1024x300-1.jpgProducts 1024X300https://www.angelinipharma.bg/produkti/tantum-verde/2023-04-04yearly0.8https://www.angelinipharma.bg/produkti/polinail/2023-04-04yearly0.8https://www.angelinipharma.bg/produkti/rosalgin/2023-04-04yearly0.8https://www.angelinipharma.bg/produkti/feminella/2023-04-04yearly0.8https://www.angelinipharma.bg/produkti/aulin-gel/2023-04-04yearly0.8https://www.angelinipharma.bg/produkti/aulin/2023-04-04yearly0.8https://www.angelinipharma.bg/produkti/trittico/2023-04-04yearly0.8https://www.angelinipharma.bg/produkti/libretto/2023-04-04yearly0.8https://www.angelinipharma.bg/produkti/acutil/2023-04-04yearly0.8https://www.angelinipharma.bg/produkti/latuda/2023-04-04yearly0.8https://www.angelinipharma.bg/otgovornost/proekti/2023-04-04yearly0.8https://www.angelinipharma.bg/media/zdybfg5h/projects.jpgProjectshttps://www.angelinipharma.bg/otgovornost/proekti/headway/2024-11-20yearly0.8https://www.angelinipharma.bg/media/ce5lp45y/ap23_g_1030_bh_home.jpgAp23 G 1030 Bh Homehttps://www.angelinipharma.bg/otgovornost/proekti/headway/headway-nova-p-tna-karta-v-oblastta-na-psikhichnoto-zdrave/2024-11-28yearly0.8https://www.angelinipharma.bg/media/yrrjlzcz/mental-health-2.jpgMental Health 2https://www.angelinipharma.bg/otgovornost/proekti/headway/headway-nova-p-tna-karta-v-oblastta-na-psikhichnoto-zdrave/zaklyucheniya-ot-posledniya-doklad-za-psikhichnoto-zdrave-na-headway-priziv-za-deistvie-za-psikhichno-zdrave/2024-11-28yearly0.8https://www.angelinipharma.bg/media/jyhogt5p/1682326299526.jpg1682326299526https://www.angelinipharma.bg/otgovornost/proekti/headway/headway-nova-p-tna-karta-v-oblastta-na-psikhichnoto-zdrave/otgovornost-na-zdravnata-sistema-k-m-nuzhdite-na-psikhichnoto-zdrave/2024-11-28yearly0.8https://www.angelinipharma.bg/media/4fxf2ijv/ap23_g_1030_bh_01_assistenza.jpgAp23 G 1030 Bh 01 Assistenzahttps://www.angelinipharma.bg/otgovornost/proekti/headway/headway-nova-p-tna-karta-v-oblastta-na-psikhichnoto-zdrave/sposobnostta-na-sofialnite-i-obrazovatelnite-sistemi-da-posreshnat-nuzhdite-na-khorata-s-psikhichni-razstroistva/2024-11-28yearly0.8https://www.angelinipharma.bg/media/224ay3bp/ap23_g_1030_bh_02_healthcare.jpgAp23 G 1030 Bh 02 Healthcarehttps://www.angelinipharma.bg/otgovornost/proekti/headway/headway-nova-p-tna-karta-v-oblastta-na-psikhichnoto-zdrave/epidemichnata-eko-trevozhnost-razgadavane-na-psikhichnoto-zdrave-na-evropa-v-usloviyata-na-izmenenieto-na-klimata/2024-11-28yearly0.8https://www.angelinipharma.bg/media/51znarve/ap23_g_1030_bh_03_ecoa.jpgAp23 G 1030 Bh 03 Ecoahttps://www.angelinipharma.bg/otgovornost/proekti/headway/headway-nova-p-tna-karta-v-oblastta-na-psikhichnoto-zdrave/kak-faktorite-na-okolnata-sreda-vliyayat-v-rkhu-psikhichnoto-zdrave-v-evropa/2024-11-28yearly0.8https://www.angelinipharma.bg/media/numotbrp/ap23_g_1030_impatti01-1.jpgAp23 G 1030 Impatti01 (1)https://www.angelinipharma.bg/otgovornost/proekti/headway/headway-nova-p-tna-karta-v-oblastta-na-psikhichnoto-zdrave/chestota-na-psikhichnite-razstroistva-v-evropeiskite-d-rzhavi/2024-11-28yearly0.8https://www.angelinipharma.bg/media/aa0l0tgd/ap23_g_1030_impatti02.jpgAp23 G 1030 Impatti02https://www.angelinipharma.bg/otgovornost/proekti/headway/headway-nova-p-tna-karta-v-oblastta-na-psikhichnoto-zdrave/ikonomicheskoto-v-zdeistvie-na-psikhichnite-razstroistva-v-evropa-znachenieto-na-prevenfiyata-na-rabotnite-mesta-i-v-uchilishata/2024-11-28yearly0.8https://www.angelinipharma.bg/media/10llb0to/ap23_g_1030_impatti03.jpgAp23 G 1030 Impatti03https://www.angelinipharma.bg/otgovornost/proekti/headway/headway-nova-p-tna-karta-za-zdraveto-na-moz-ka-akfent-v-rkhu-epilepsiya/2024-11-20yearly0.8https://www.angelinipharma.bg/media/btnnczo1/epilepsy.jpgEpilepsyhttps://www.angelinipharma.bg/otgovornost/mnogoobrazie-i-priobshavane/2025-10-08yearly0.8https://www.angelinipharma.bg/media/5u1lu5ba/d-i.jpgD&Ihttps://www.angelinipharma.bg/otgovornost/mnogoobrazie-i-priobshavane/nashiyat-angazhiment/2023-04-04yearly0.8https://www.angelinipharma.bg/media/0dnpwnzs/commitment.jpgCommitmenthttps://www.angelinipharma.bg/otgovornost/mnogoobrazie-i-priobshavane/nashiyat-nachin-na-deistvie/2024-11-20yearly0.8https://www.angelinipharma.bg/media/cuuhhmac/people-1.jpgPeople 1https://www.angelinipharma.bg/otgovornost/mnogoobrazie-i-priobshavane/nashite-s-trudnichestva/2023-04-04yearly0.8https://www.angelinipharma.bg/media/i41lhsus/partnership.jpgPartnershiphttps://www.angelinipharma.bg/otgovornost/headway-2020/2023-04-04yearly0.8https://www.angelinipharma.bg/media/lnlf0hk0/headway2021_website.jpgHeadway2021 Websitehttps://www.angelinipharma.bg/otgovornost/etichnost/2026-01-21yearly0.8https://www.angelinipharma.bg/media/cylhiag5/ethics_1030.jpgEthics 1030https://www.angelinipharma.bg/otgovornost/politika-za-kachestvo/2025-10-08yearly0.8https://www.angelinipharma.bg/media/hz2fjprz/qualityhero-1.jpgQualityhero (1)https://www.angelinipharma.bg/otgovornost/prozrachnost/2025-10-08yearly0.8https://www.angelinipharma.bg/media/3e0krnfb/focus-s.jpgdiversityhttps://www.angelinipharma.bg/otgovornost/prozrachnost/hungary/2023-04-04yearly0.8https://www.angelinipharma.bg/otgovornost/prozrachnost/slovak-republic/2023-04-04yearly0.8https://www.angelinipharma.bg/otgovornost/prozrachnost/other-countries/2023-04-04yearly0.8https://www.angelinipharma.bg/mediya/2023-04-04monthly0.9https://www.angelinipharma.bg/mediya/novini-i-press-obsheniya/2025-10-10monthly0.9https://www.angelinipharma.bg/media/bwvpigmx/testata_area_news.jpgAngelini Pharma | Newshttps://www.angelinipharma.bg/mediya/novini-i-press-obsheniya/headway-2023-indeks-za-psikhichno-zdrave/2023-04-04yearly0.8https://www.angelinipharma.bg/media/2ttel2q4/ap_headway2023_1030x302.jpgAP Headway2023 1030X302https://www.angelinipharma.bg/mediya/novini-i-press-obsheniya/sresha-za-inovafii-v-psikhiatriyata/2023-04-04yearly0.8https://www.angelinipharma.bg/media/5mgj4yu0/testata_1024x300.jpgTestata 1024X300 (1)https://www.angelinipharma.bg/mediya/novini-i-press-obsheniya/ial-kamnanii/2023-04-04yearly0.8https://www.angelinipharma.bg/media/4wentcvv/ap_argobio_1440x500.jpgAP Argobio 1440X500https://www.angelinipharma.bg/mediya/novini-i-press-obsheniya/mezhdunaroden-den-na-epilepsiyata/2023-04-04yearly0.8https://www.angelinipharma.bg/media/jcjp5ido/header-website.jpgHeader Websitehttps://www.angelinipharma.bg/mediya/novini-i-press-obsheniya/nov-doklad-na-headway-podchertava-ekologichnite-determinanti-na-psikhichnoto-zdrave/2023-04-04yearly0.8https://www.angelinipharma.bg/media/nx4akzjc/headway.jpgHeadwayhttps://www.angelinipharma.bg/mediya/novini-i-press-obsheniya/angelini-industries-naznachava-dzhakopo-andreoze-za-nov-seo-na-angelini-pharma/2023-04-04yearly0.8https://www.angelinipharma.bg/media/vtpjplf5/new-ceo.jpgNew CEOhttps://www.angelinipharma.bg/mediya/novini-i-press-obsheniya/say-no-to-pain-talk-to-your-oncologist/2023-04-04yearly0.8https://www.angelinipharma.bg/media/ntcbwbgc/web-slider-home.jpgWeb Slider Homehttps://www.angelinipharma.bg/mediya/novini-i-press-obsheniya/angelini-pharma-celebrates-purple-day-a-day-dedicated-to-increasing-awareness-about-epilepsy-worldwide/2023-04-04yearly0.8https://www.angelinipharma.bg/media/vupbi23p/ap23_g_1030_purpleday-1.jpgAP23 G 1030 Purpleday (1)https://www.angelinipharma.bg/mediya/novini-i-press-obsheniya/andzhelini-farma-se-pris-edinyava-k-m-kongresa-na-ean-2024-za-da-podkrepi-postignatite-v-rkhovi-rezultati-v-oblastta-na-nevrologiyata-i-lechenieto-na-epilepsiya/2024-07-02yearly0.8https://www.angelinipharma.bg/media/nxlljfjc/ap24_g_1030_openinginnovation.jpgAP24 G 1030 Openinginnovationhttps://www.angelinipharma.bg/mediya/novini-i-press-obsheniya/andzhelini-farma-predstavya-danni-za-fenobamat-pokazvashi-ustoichiva-polza-pri-v-zrastni-s-epilepsiya/2024-09-09yearly0.8https://www.angelinipharma.bg/mediya/novini-i-press-obsheniya/nov-doklad-na-headway-uvelicheni-investifii-v-psikhichnoto-zdrave-she-spestyat-na-evropa-122-9-mlrd-evro/2024-10-08yearly0.8https://www.angelinipharma.bg/media/uj0he14g/ap24_g_1440_resilience.jpgAP24 G 1440 Resiliencehttps://www.angelinipharma.bg/mediya/novini-i-press-obsheniya/andzhelini-farma-sklyuchi-dogovor-s-cureverse-i-she-mozhe-da-lifenzira-razvitieto-i-t-rgoviyata-s-novi-produkti-za-moz-chnoto-zdrave/2024-10-24yearly0.8https://www.angelinipharma.bg/media/uzkp4jd0/ap24_g_1440_cs_accordo.jpgAP24 G 1440 Cs Accordohttps://www.angelinipharma.bg/mediya/novini-i-press-obsheniya/grin-therapeutics-i-andzhelini-farma-sklyuchvat-ekskluzivno-partn-orstvo-za-razrabotvane-i-komersializafiya-na-radiprodil-izv-n-severna-amerika/2025-06-06yearly0.8https://www.angelinipharma.bg/media/b1umyfzf/ap25_g_1030_epilepsy-for-grin-post.jpgAP25 G 1030 Epilepsy For GRIN Post (2)https://www.angelinipharma.bg/mediya/novini-i-press-obsheniya/andzhelini-farma-predstavya-danni-koito-dokazvat-polzite-ot-fenobamat-za-v-zrastni-s-nekontrolirana-epilepsiya/2025-09-24yearly0.8https://www.angelinipharma.bg/media/qljbv1za/header_congress_1030-1.jpgCenobamatehttps://www.angelinipharma.bg/mediya/novini-i-press-obsheniya/angelini-pharma-i-quiver-bioscience-sklyuchikha-sporazumenie-za-razrabotvane-na-novi-terapevtichni-sredstva-za-genetichni-epilepsii/2026-03-13yearly0.8https://www.angelinipharma.bg/media/uvsbnnqz/header-website_quiver-accordo_1440x480_v2.jpgNews Quiverhttps://www.angelinipharma.bg/media/wbmfdsur/angelini-pharma_company-profile_en-2024.pdf2025-10-10yearly0.8https://www.angelinipharma.bg/media/eyhlnipf/presskit.jpgPresskithttps://www.angelinipharma.bg/mediya/medien-fent-r/2023-04-04monthly0.9https://www.angelinipharma.bg/mediya/medien-fent-r/angelini-pharma-korporativno-video/2023-04-04yearly0.8https://www.angelinipharma.bg/mediya/medien-fent-r/epilepsiya/2023-04-04yearly0.8https://www.angelinipharma.bg/mediya/medien-fent-r/50miliona-st-pki-do-promyanata/2023-04-04yearly0.8https://www.angelinipharma.bg/mediya/medien-fent-r/angelini-pharma-povedenie/2023-04-04yearly0.8https://www.angelinipharma.bg/politika-za-biskvitki/2024-11-27never0.5https://www.angelinipharma.bg/obshi-pravila-za-polzvane/2024-11-27never0.5https://www.angelinipharma.bg/politika-za-poveritelnost/2024-11-27never0.5https://www.angelinipharma.bg/karta-na-saita/2023-04-04never0.5https://www.angelinipharma.bg/lekarstvena-bezopasnost/2023-04-04never0.5